.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01D_CytotoxicAntibioticsAndRelatedSubstances.L01DB04_Aclarubicin.Aclarubicin .Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01D_CytotoxicAntibioticsAndRelatedSubstances.L01DB04_Aclarubicin.Aclarubicin| name: | Aclarubicin |
| ATC code: | L01DB04 | route: | intravenous |
| n-compartments | 2 |
Aclarubicin is an anthracycline antibiotic that was previously used as a chemotherapy agent mainly for the treatment of acute leukemia and some solid tumors. Its use has become limited or obsolete in many countries, and it is generally not used as a first-line therapy today due to the availability of better tolerated and more effective alternatives.
Pharmacokinetic parameters estimated for adult patients based on published sources about aclarubicin after intravenous administration.